Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma
SALVINI, MARCOFirst
;BONELLO, FRANCESCA;BOCCADORO, Mario;LAROCCA, Alessandra
Last
2017-01-01
File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
[Published Vsn.] Salvini et al - 2017 - Exp Rev Anticancer Th - Management of AEs.pdf
Accesso riservato
Descrizione: [Restricted access - Published Vsn.] Salvini M et al. Expert Rev Anticancer Ther . 2017 Jan;17(1):75-87. doi: 10.1080/14737140.2017.1266264. Epub 2016 Dec 9. © 2016 Informa UK Limited, trading as Taylor & Francis Group. Available at: https://www.tandfonline.com/doi/abs/10.1080/14737140.2017.1266264?journalCode=iery20 | https://doi.org/10.1080/14737140.2017.1266264
Tipo di file:
PDF EDITORIALE
Dimensione
1.32 MB
Formato
Adobe PDF
|
1.32 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
[Restricted access - Author Vsn] Salvini et al - 2017 - Expert Review of Anticancer Therapy - Management of Adverse Events - Post Print.pdf
Open Access dal 02/02/2018
Descrizione: Author Version. Salvini M et al. Expert Rev Anticancer Ther . 2017 Jan;17(1):75-87. doi: 10.1080/14737140.2017.1266264. Epub 2016 Dec 9. © 2016 Informa UK Limited, trading as Taylor & Francis Group. The published version is available at: https://www.tandfonline.com/doi/abs/10.1080/14737140.2017.1266264?journalCode=iery20 | https://doi.org/10.1080/14737140.2017.1266264 . When citing, please refer to the published version.
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
785.26 kB
Formato
Adobe PDF
|
785.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.